Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis.

Nakano J, Hashizume K, Fukushima T, Ueno K, Matsuura E, Ikio Y, Ishii S, Morishita S, Tanaka K, Kusuba Y.

Integr Cancer Ther. 2018 Dec;17(4):1048-1058. doi: 10.1177/1534735418807555. Epub 2018 Oct 23.

2.

Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.

Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, Takashima H, Nishioka K, Hattori N.

Acta Neuropathol Commun. 2018 Oct 17;6(1):105. doi: 10.1186/s40478-018-0617-y.

3.

Peripheral neuropathy in a case with CADASIL: a case report.

Sakiyama Y, Matsuura E, Maki Y, Yoshimura A, Ando M, Nomura M, Shinohara K, Saigo R, Nakamura T, Hashiguchi A, Takashima H.

BMC Neurol. 2018 Aug 31;18(1):134. doi: 10.1186/s12883-018-1131-3.

4.

[Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].

Nakamura D, Hayashida M, Kubota K, Matsuura E, Tabuchi T, Arima N, Inoue H, Yoshimitsu M, Ishitsuka K.

Rinsho Ketsueki. 2018;59(5):489-491. doi: 10.11406/rinketsu.59.489. Japanese.

PMID:
29877235
5.

Mutations in COA7 cause spinocerebellar ataxia with axonal neuropathy.

Higuchi Y, Okunushi R, Hara T, Hashiguchi A, Yuan J, Yoshimura A, Murayama K, Ohtake A, Ando M, Hiramatsu Y, Ishihara S, Tanabe H, Okamoto Y, Matsuura E, Ueda T, Toda T, Yamashita S, Yamada K, Koide T, Yaguchi H, Mitsui J, Ishiura H, Yoshimura J, Doi K, Morishita S, Sato K, Nakagawa M, Yamaguchi M, Tsuji S, Takashima H.

Brain. 2018 Jun 1;141(6):1622-1636. doi: 10.1093/brain/awy104.

6.

Corrigendum to "Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes".

Tan XW, Bhave M, Fong AYY, Matsuura E, Kobayashi K, Shen LH, Hwang SS.

Oxid Med Cell Longev. 2018 Jan 22;2018:3136860. doi: 10.1155/2018/3136860. eCollection 2018.

7.

Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome.

Ames PRJ, Lopez LL, Merashli M, Matsuura E.

Auto Immun Highlights. 2018 Feb 10;9(1):2. doi: 10.1007/s13317-018-0103-3. No abstract available.

8.

Clinical and genetic features of Charcot-Marie-Tooth disease 2F and hereditary motor neuropathy 2B in Japan.

Tanabe H, Higuchi Y, Yuan JH, Hashiguchi A, Yoshimura A, Ishihara S, Nozuma S, Okamoto Y, Matsuura E, Ishiura H, Mitsui J, Takashima R, Kokubun N, Maeda K, Asano Y, Sunami Y, Kono Y, Ishigaki Y, Yanamoto S, Fukae J, Kida H, Morita M, Tsuji S, Takashima H.

J Peripher Nerv Syst. 2018 Mar;23(1):40-48. doi: 10.1111/jns.12252. Epub 2018 Feb 14.

9.

The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Saito M, Sejima H, Naito T, Ushirogawa H, Matsuzaki T, Matsuura E, Tanaka Y, Nakamura T, Takashima H.

Virol J. 2017 Dec 4;14(1):234. doi: 10.1186/s12985-017-0902-6.

10.

[A amyotrophic lateral sclerosis (ALS) 4 family misdiagnosed as hereditary spastic paraplegia-a case report].

Taniguchi T, Hokezu Y, Okada T, Ishibashi M, Hashiguchi A, Matsuura E, Takashima H.

Rinsho Shinkeigaku. 2017 Nov 25;57(11):685-690. doi: 10.5692/clinicalneurol.cn-000996. Epub 2017 Oct 26. Japanese.

PMID:
29070749
11.

Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban.

Kadohira Y, Yamada S, Matsuura E, Hayashi T, Morishita E, Nakao S, Asakura H.

Intern Med. 2017 Nov 1;56(21):2913-2917. doi: 10.2169/internalmedicine.8666-16. Epub 2017 Sep 25.

12.

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.

Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J.

Mol Ther Methods Clin Dev. 2017 May 25;6:31-39. doi: 10.1016/j.omtm.2017.05.006. eCollection 2017 Sep 15.

13.

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.

Nozuma S, Matsuura E, Kodama D, Tashiro Y, Matsuzaki T, Kubota R, Izumo S, Takashima H.

Retrovirology. 2017 Apr 19;14(1):26. doi: 10.1186/s12977-017-0350-9.

14.

Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.

Li X, Xu P, Wang C, Xu N, Xu A, Xu Y, Sadahira T, Araki M, Wada K, Matsuura E, Watanabe M, Zheng J, Sun P, Huang P, Nasu Y, Liu C.

Oncotarget. 2017 Mar 28;8(13):21177-21186. doi: 10.18632/oncotarget.15505.

15.

The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARγ.

Li J, Xiu Z, Wang R, Yu C, Chi Y, Qin J, Fu C, Matsuura E, Liu Q.

Life Sci. 2017 May 15;177:27-40. doi: 10.1016/j.lfs.2017.03.024. Epub 2017 Apr 2.

PMID:
28377266
16.

In vivo distribution of single chain variable fragment (scFv) against atherothrombotic oxidized LDL/β2-glycoprotein I complexes into atherosclerotic plaques of WHHL rabbits: Implication for clinical PET imaging.

Sasaki T, Kobayashi K, Kita S, Kojima K, Hirano H, Shen L, Takenaka F, Kumon H, Matsuura E.

Autoimmun Rev. 2017 Feb;16(2):159-167. doi: 10.1016/j.autrev.2016.12.007. Epub 2016 Dec 15. Review.

PMID:
27988435
17.

Enhanced cellular uptake of lactosomes using cell-penetrating peptides.

Akahoshi A, Matsuura E, Ozeki E, Matsui H, Watanabe K, Ohtsuki T.

Sci Technol Adv Mater. 2016 Jun 8;17(1):245-252. eCollection 2016.

18.

HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.

Matsuura E, Nozuma S, Tashiro Y, Kubota R, Izumo S, Takashima H.

J Neurol Sci. 2016 Dec 15;371:112-116. doi: 10.1016/j.jns.2016.10.030. Epub 2016 Oct 21.

19.

Erratum to: Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.

Ishidou Y, Matsuyama K, Matsuura E, Setoguchi T, Nagano S, Kakoi H, Hirotsu M, Kawamura I, Yamamoto T, Komiya S.

Cell Tissue Bank. 2017 Mar;18(1):129. doi: 10.1007/s10561-016-9591-4. No abstract available.

PMID:
27770291
20.

Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease.

Matsuura E, Enose-Akahata Y, Yao K, Oh U, Tanaka Y, Takashima H, Jacobson S.

J Neuroimmunol. 2017 Mar 15;304:43-50. doi: 10.1016/j.jneuroim.2016.09.014. Epub 2016 Oct 3.

21.

Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.

Ishidou Y, Matsuyama K, Matsuura E, Setoguchi T, Nagano S, Kakoi H, Hirotsu M, Kawamura I, Yamamoto T, Komiya S.

Cell Tissue Bank. 2016 Dec;17(4):555-560. Epub 2016 Sep 27. Erratum in: Cell Tissue Bank. 2017 Mar;18(1):129.

22.

Cytoprotective and Cytotoxic Effects of Rice Bran Extracts in Rat H9c2(2-1) Cardiomyocytes.

Tan XW, Bhave M, Fong AY, Matsuura E, Kobayashi K, Shen LH, Hwang SS.

Oxid Med Cell Longev. 2016;2016:6943053. doi: 10.1155/2016/6943053. Epub 2016 Apr 27. Erratum in: Oxid Med Cell Longev. 2018 Jan 22;2018:3136860.

23.

Ultrastructural Changes Associated with Reversible Stiffening in Catch Connective Tissue of Sea Cucumbers.

Tamori M, Ishida K, Matsuura E, Ogasawara K, Hanasaka T, Takehana Y, Motokawa T, Osawa T.

PLoS One. 2016 May 18;11(5):e0155673. doi: 10.1371/journal.pone.0155673. eCollection 2016.

24.

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.

Xu P, Xu N, Guo K, Xu A, Takenaka F, Matsuura E, Liu C, Kumon H, Huang P.

Oncotarget. 2016 May 31;7(22):33025-34. doi: 10.18632/oncotarget.8846.

25.

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Nozuma S, Matsuura E, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H.

PLoS One. 2016 Mar 30;11(3):e0152954. doi: 10.1371/journal.pone.0152954. eCollection 2016. No abstract available.

26.

Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.

Higuchi Y, Hashiguchi A, Yuan J, Yoshimura A, Mitsui J, Ishiura H, Tanaka M, Ishihara S, Tanabe H, Nozuma S, Okamoto Y, Matsuura E, Ohkubo R, Inamizu S, Shiraishi W, Yamasaki R, Ohyagi Y, Kira J, Oya Y, Yabe H, Nishikawa N, Tobisawa S, Matsuda N, Masuda M, Kugimoto C, Fukushima K, Yano S, Yoshimura J, Doi K, Nakagawa M, Morishita S, Tsuji S, Takashima H.

Ann Neurol. 2016 Apr;79(4):659-72. doi: 10.1002/ana.24612. Epub 2016 Mar 17.

27.

The Function of β2-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts.

Wahyuningsih AT, Shen L, Kobayashi K, Sasaki T, Takenaka F, Hanada T, Akehi M, Akahoshi A, Ozeki E, Ando E, Matsuura E.

Acta Med Okayama. 2016;70(1):13-24.

28.

Toxocara canis myelitis involving the lumbosacral region: a case report.

Hiramatsu Y, Yoshimura M, Saigo R, Arata H, Okamoto Y, Matsuura E, Maruyama H, Takashima H.

J Spinal Cord Med. 2017 Mar;40(2):241-245. doi: 10.1080/10790268.2015.1114230. Epub 2015 Dec 17.

29.

Assessment of olfactory detection thresholds in children with autism spectrum disorders using a pulse ejection system.

Kumazaki H, Muramatsu T, Fujisawa TX, Miyao M, Matsuura E, Okada K, Kosaka H, Tomoda A, Mimura M.

Mol Autism. 2016 Jan 19;7:6. doi: 10.1186/s13229-016-0071-2. eCollection 2016.

30.

New type of encephalomyelitis responsive to trimethoprim/sulfamethoxazole treatment in Japan.

Sakiyama Y, Kanda N, Higuchi Y, Yoshimura M, Wakaguri H, Takata Y, Watanabe O, Yuan J, Tashiro Y, Saigo R, Nozuma S, Yoshimura A, Arishima S, Ikeda K, Shinohara K, Arata H, Michizono K, Higashi K, Hashiguchi A, Okamoto Y, Hirano R, Shiraishi T, Matsuura E, Okubo R, Higuchi I, Goto M, Hirano H, Sano A, Iwasaki T, Matsuda F, Izumo S, Takashima H.

Neurol Neuroimmunol Neuroinflamm. 2015 Aug 13;2(5):e143. doi: 10.1212/NXI.0000000000000143. eCollection 2015 Oct.

31.

A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.

Guo K, Huang P, Xu N, Xu P, Kaku H, Zheng S, Xu A, Matsuura E, Liu C, Kumon H.

Oncotarget. 2015 Aug 28;6(25):21137-47.

32.

Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan.

Tada Y, Yagi K, Uno M, Matsushita N, Kanematsu Y, Kuwayama K, Shimada K, Nishi K, Hirasawa M, Satomi J, Kitazato KT, Kageji T, Matsuura E, Nagahiro S.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1487-92. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.015. Epub 2015 Apr 16.

33.

Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Matsuura E, Yoshimura A, Nozuma S, Higuchi I, Kubota R, Takashima H.

BMC Neurol. 2015 Feb 28;15:18. doi: 10.1186/s12883-015-0275-7.

34.

A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.

Kobayashi K, Sasaki T, Takenaka F, Yakushiji H, Fujii Y, Kishi Y, Kita S, Shen L, Kumon H, Matsuura E.

J Immunol Res. 2015;2015:268172. doi: 10.1155/2015/268172. Epub 2015 Mar 25.

35.

Positron emission tomography to elucidate pharmacokinetic differences of regioisomeric retinoid x receptor agonists.

Kobayashi T, Furusawa Y, Yamada S, Akehi M, Takenaka F, Sasaki T, Akahoshi A, Hanada T, Matsuura E, Hirano H, Tai A, Kakuta H.

ACS Med Chem Lett. 2015 Jan 20;6(3):334-8. doi: 10.1021/ml500511m. eCollection 2015 Mar 12.

36.

Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs.

Hashiguchi A, Higuchi Y, Nomura M, Nakamura T, Arata H, Yuan J, Yoshimura A, Okamoto Y, Matsuura E, Takashima H.

J Peripher Nerv Syst. 2014 Dec;19(4):311-6. doi: 10.1111/jns.12102.

PMID:
25583183
37.

In vitro effect of Paullinia cupana (guaraná) on hydrophobicity, biofilm formation, and adhesion of Candida albicans' to polystyrene, composites, and buccal epithelial cells.

Matsuura E, Godoy JS, Bonfim-Mendonça Pde S, de Mello JC, Svidzinski TI, Gasparetto A, Maciel SM.

Arch Oral Biol. 2015 Mar;60(3):471-8. doi: 10.1016/j.archoralbio.2014.05.026. Epub 2014 Jun 9.

PMID:
25543106
38.

Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Matsuura E, Kubota R, Tanaka Y, Takashima H, Izumo S.

J Neuropathol Exp Neurol. 2015 Jan;74(1):2-14. doi: 10.1097/NEN.0000000000000141.

39.

Partial deficiency of emerin caused by a splice site mutation in EMD.

Yuan J, Ando M, Higuchi I, Sakiyama Y, Matsuura E, Michizono K, Watanabe O, Nagano S, Inamori Y, Hashiguchi A, Higuchi Y, Yoshimura A, Takashima H.

Intern Med. 2014;53(14):1563-8. Epub 2014 Jul 15.

40.

Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.

Li J, Chi Y, Liu S, Wang L, Wang R, Han X, Matsuura E, Liu Q.

J Clin Immunol. 2014 Aug;34(6):669-76. doi: 10.1007/s10875-014-0063-y. Epub 2014 Jun 27.

PMID:
24970589
41.

7-ketocholesteryl-9-carboxynonanoate enhances ATP binding cassette transporter A1 expression mediated by PPARγ in THP-1 macrophages.

Chi Y, Wang L, Liu Y, Ma Y, Wang R, Han X, Qiao H, Lin J, Matsuura E, Liu S, Liu Q.

Atherosclerosis. 2014 Jun;234(2):461-8. doi: 10.1016/j.atherosclerosis.2014.01.052. Epub 2014 Feb 15.

PMID:
24814410
42.

Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Nozuma S, Matsuura E, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H.

PLoS One. 2014 May 6;9(5):e86144. doi: 10.1371/journal.pone.0086144. eCollection 2014. Erratum in: PLoS One. 2016;11(3):e0152954.

43.

Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.

Lopez LR, Guyer KE, Torre IG, Pitts KR, Matsuura E, Ames PR.

World J Diabetes. 2014 Apr 15;5(2):115-27. doi: 10.4239/wjd.v5.i2.115. Review.

44.

Is atherosclerosis an autoimmune disease?

Matsuura E, Atzeni F, Sarzi-Puttini P, Turiel M, Lopez LR, Nurmohamed MT.

BMC Med. 2014 Mar 18;12:47. doi: 10.1186/1741-7015-12-47. Review.

45.

Ectopic calcification: importance of common nanoparticle scaffolds containing oxidized acidic lipids.

Kumon H, Matsuura E, Nagaoka N, Yamamoto T, Uehara S, Araki M, Matsunami Y, Kobayashi K, Matsumoto A.

Nanomedicine. 2014 Feb;10(2):441-50. doi: 10.1016/j.nano.2013.08.010. Epub 2013 Sep 9.

PMID:
24028895
46.

RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.

Okada Y, Watanabe M, Nakai T, Kamikawa Y, Shimizu M, Fukuhara Y, Yonekura M, Matsuura E, Hoshika Y, Nagai R, Aird WC, Doi T.

J Thromb Haemost. 2013 Sep;11(9):1742-50. doi: 10.1111/jth.12355.

47.

Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation.

Yuan J, Matsuura E, Higuchi Y, Hashiguchi A, Nakamura T, Nozuma S, Sakiyama Y, Yoshimura A, Izumo S, Takashima H.

Neurology. 2013 Apr 30;80(18):1641-9. doi: 10.1212/WNL.0b013e3182904fdd. Epub 2013 Apr 17.

PMID:
23596073
48.

Novel mutation in the replication focus targeting sequence domain of DNMT1 causes hereditary sensory and autonomic neuropathy IE.

Yuan J, Higuchi Y, Nagado T, Nozuma S, Nakamura T, Matsuura E, Hashiguchi A, Sakiyama Y, Yoshimura A, Takashima H.

J Peripher Nerv Syst. 2013 Mar;18(1):89-93. doi: 10.1111/jns5.12012.

PMID:
23521649
49.

A purification system for 64Cu produced by a biomedical cyclotron for antibody PET imaging.

Toyota T, Hanafusa T, Oda T, Koumura I, Sasaki T, Matsuura E, Kumon H, Yano T, Ono T.

J Radioanal Nucl Chem. 2013;298(1):295-300. Epub 2012 Dec 6.

50.

Molluscum contagiosum on the lip.

Matsuura E, Tsunemi Y, Kawashima M.

J Dermatol. 2013 Feb;40(2):137. doi: 10.1111/1346-8138.12029. Epub 2012 Dec 6. No abstract available.

PMID:
23216267

Supplemental Content

Loading ...
Support Center